Flutter Entertainment beats Q3 earnings estimate despite sports results impact
NEW YORK - Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) has expanded into the Egyptian market with its first microwave ablation (MWA) procedure performed at Ain Shams Specialized Hospital, the company announced Monday. The expansion comes as Baird continues to grow its revenue at an impressive 17.74% year-over-year rate.
The procedure involved a bone ablation on a 30-year-old male patient with a 1 x 1.5 cm bone lesion in the left thigh. Dr. Amr Mahmoud performed the treatment, which the company said achieved full ablation and provided pain relief to the patient.
"This first procedure at Ain Shams Specialized Hospital marks a major milestone, signifying our entry into Egypt and demonstrating the versatility of our technology in complex bone ablations," said Haimei Wu, Chairwoman of Baird Medical, in a press release statement.
Baird Medical specializes in minimally invasive diagnostic and treatment technologies, with a focus on microwave ablation systems. The company’s products are currently used in over 30 hospitals across the United States, including Johns Hopkins Hospital and Columbia University Medical Center.
The company describes itself as the market leader in thyroid microwave ablation devices in China, with a commercial presence expanding to more than 20 countries globally.
The Egyptian market entry represents the latest step in Baird Medical’s international expansion strategy for its minimally invasive treatment technologies, according to the press release.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.